Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Medical Central Imaging Service Market by Type (Standardized Reading Protocols, Central Expert Image Analysis, Image Quality Control, Others), By Application (Pharmaceutical, Research Institutes, Biotechnology, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Medical Central Imaging Service Market by Type (Standardized Reading Protocols, Central Expert Image Analysis, Image Quality Control, Others), By Application (Pharmaceutical, Research Institutes, Biotechnology, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 256831 4200 Medical Care 377 243 Pages 4.6 (49)
                                          

Market Overview:


The global medical central imaging service market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing demand for centralized image interpretation and analysis services, rising prevalence of chronic diseases, and growing number of diagnostic procedures. In addition, the increasing use of medical images for research purposes is also contributing to the growth of this market. On the basis of type, the global medical central imaging service market can be segmented into standardized reading protocols, central expert image analysis, image quality control, and others. Central expert image analysis is expected to grow at a higher CAGR during the forecast period as it offers advantages such as improved accuracy and efficiency in diagnosis and treatment decisions. On the basis of application, the global medical central imaging service market can be segmented into pharmaceuticals industry; research institutes; biotechnology industry; hospitals & clinics; other diagnostic centers; academic & government research organizations; veterinary medicine field ;and others (including agricultural). The pharmaceuticals industry accounted for majority share in 2017 owing to rising demand for early diagnosis and treatment options for various chronic diseases such as cancer and heart disease . However ,the biotechnology sector is projectedto witness highest CAGR during 2018-2030 due its growing applications in life sciences R&D activities . Regionally , North America held largest share in 2017 followed by Europe due high adoption rateof advanced technologiesin these regions .


Global Medical Central Imaging Service Industry Outlook


Product Definition:


A medical central imaging service is a centralized location for the storage, retrieval, and analysis of medical images. The importance of a medical central imaging service is that it provides a single location for all of your medical images, which makes it easy to access them when you need them.


Standardized Reading Protocols:


A standardized reading protocols is a set of rules which defines the procedure for scanning and reading images in medical central imaging services. The growing demand for efficiency in medical procedures along with the rising number of diagnostic centers are some factors attributing to its high growth rate. Furthermore, increasing adoption of automated systems by radiologists worldwide is also expected to drive market growth over the forecast period.


Central Expert Image Analysis:


Central expert image analysis is a new term in the medical imaging market. It means that an independent and third-party company will be providing consulting services to hospitals or healthcare providers for their diagnostic imaging needs. These companies are experts in analyzing the images received from various medical devices and provide reports with their findings.


These reports contain recommendations on how to improve patient care by using available resources more efficiently, thus helping reduce costs while improving quality outcomes.


Application Insights:


The pharmaceutical application segment dominated the global market in 2017. The growth of this segment can be attributed to factors such as increasing adoption of imaging techniques for quality control and tracking purposes in the pharmaceutical industry. Furthermore, an increase in product launches by various companies is expected to boost demand over the forecast period. For instance, on June 26, 2018 Merck KGaA announced that it has received FDA approval for its new pain management drug Vioxx (rofecoxib) tablets for injection into a muscle called myotonic dystrophy type 2G (DM2G). This approval was based on data from clinical trials which showed that rofecoxib given by vein had fewer adverse effects than when it is given by mouth.


Regional Analysis:


North America dominated the global market in 2017. This can be attributed to factors such as favorable reimbursement scenario, presence of key players, and increasing adoption of advanced technologies. Moreover, growing number of research projects is expected to drive regional growth over the forecast period. Asia Pacific is anticipated to witness lucrative CAGR during the forecast period owing to rising healthcare expenditure and improving healthcare infrastructure in emerging countries like China and India. Furthermore, increasing prevalence of chronic diseases coupled with government initiatives for creating awareness about early diagnosis are some other factors driving this region’s growth.


Growth Factors:


  • Increasing demand for early and accurate diagnosis of diseases
  • Rising prevalence of chronic diseases
  • Technological advancements in medical imaging equipment
  • Growing number of private diagnostic centers and hospitals
  • Increasing awareness about the benefits of medical imaging services

Scope Of The Report

Report Attributes

Report Details

Report Title

Medical Central Imaging Service Market Research Report

By Type

Standardized Reading Protocols, Central Expert Image Analysis, Image Quality Control, Others

By Application

Pharmaceutical, Research Institutes, Biotechnology, Others

By Companies

ICON, ERT, McLaren, Bioclinica, Parexel, BioTelemetry, ProScan Imaging, Imaging Endpoints, Radiant Sage, Micron, Inc., Intrinsic Imaging, Median Technologies, Cardiovascular Imaging Technologies, Banook Group

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

243

Number of Tables & Figures

171

Customization Available

Yes, the report can be customized as per your need.


Global Medical Central Imaging Service Market Report Segments:

The global Medical Central Imaging Service market is segmented on the basis of:

Types

Standardized Reading Protocols, Central Expert Image Analysis, Image Quality Control, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Pharmaceutical, Research Institutes, Biotechnology, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. ICON
  2. ERT
  3. McLaren
  4. Bioclinica
  5. Parexel
  6. BioTelemetry
  7. ProScan Imaging
  8. Imaging Endpoints
  9. Radiant Sage
  10. Micron, Inc.
  11. Intrinsic Imaging
  12. Median Technologies
  13. Cardiovascular Imaging Technologies
  14. Banook Group

Global Medical Central Imaging Service Market Overview


Highlights of The Medical Central Imaging Service Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Standardized Reading Protocols
    2. Central Expert Image Analysis
    3. Image Quality Control
    4. Others
  1. By Application:

    1. Pharmaceutical
    2. Research Institutes
    3. Biotechnology
    4. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Medical Central Imaging Service Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Medical Central Imaging Service Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Medical Central Imaging Service is a medical imaging company that provides services such as MRI, CT scans, and X-rays.

Some of the key players operating in the medical central imaging service market are ICON, ERT, McLaren, Bioclinica, Parexel, BioTelemetry, ProScan Imaging, Imaging Endpoints, Radiant Sage, Micron, Inc., Intrinsic Imaging, Median Technologies, Cardiovascular Imaging Technologies, Banook Group.

The medical central imaging service market is expected to grow at a compound annual growth rate of 7.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Medical Central Imaging Service Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Medical Central Imaging Service Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Medical Central Imaging Service Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Medical Central Imaging Service Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Medical Central Imaging Service Market Size & Forecast, 2018-2028       4.5.1 Medical Central Imaging Service Market Size and Y-o-Y Growth       4.5.2 Medical Central Imaging Service Market Absolute $ Opportunity

Chapter 5 Global Medical Central Imaging Service Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Medical Central Imaging Service Market Size Forecast by Type
      5.2.1 Standardized Reading Protocols
      5.2.2 Central Expert Image Analysis
      5.2.3 Image Quality Control
      5.2.4 Others
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Medical Central Imaging Service Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Medical Central Imaging Service Market Size Forecast by Applications
      6.2.1 Pharmaceutical
      6.2.2 Research Institutes
      6.2.3 Biotechnology
      6.2.4 Others
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Medical Central Imaging Service Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Medical Central Imaging Service Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Medical Central Imaging Service Analysis and Forecast
   9.1 Introduction
   9.2 North America Medical Central Imaging Service Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Medical Central Imaging Service Market Size Forecast by Type
      9.6.1 Standardized Reading Protocols
      9.6.2 Central Expert Image Analysis
      9.6.3 Image Quality Control
      9.6.4 Others
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Medical Central Imaging Service Market Size Forecast by Applications
      9.10.1 Pharmaceutical
      9.10.2 Research Institutes
      9.10.3 Biotechnology
      9.10.4 Others
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Medical Central Imaging Service Analysis and Forecast
   10.1 Introduction
   10.2 Europe Medical Central Imaging Service Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Medical Central Imaging Service Market Size Forecast by Type
      10.6.1 Standardized Reading Protocols
      10.6.2 Central Expert Image Analysis
      10.6.3 Image Quality Control
      10.6.4 Others
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Medical Central Imaging Service Market Size Forecast by Applications
      10.10.1 Pharmaceutical
      10.10.2 Research Institutes
      10.10.3 Biotechnology
      10.10.4 Others
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Medical Central Imaging Service Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Medical Central Imaging Service Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Medical Central Imaging Service Market Size Forecast by Type
      11.6.1 Standardized Reading Protocols
      11.6.2 Central Expert Image Analysis
      11.6.3 Image Quality Control
      11.6.4 Others
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Medical Central Imaging Service Market Size Forecast by Applications
      11.10.1 Pharmaceutical
      11.10.2 Research Institutes
      11.10.3 Biotechnology
      11.10.4 Others
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Medical Central Imaging Service Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Medical Central Imaging Service Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Medical Central Imaging Service Market Size Forecast by Type
      12.6.1 Standardized Reading Protocols
      12.6.2 Central Expert Image Analysis
      12.6.3 Image Quality Control
      12.6.4 Others
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Medical Central Imaging Service Market Size Forecast by Applications
      12.10.1 Pharmaceutical
      12.10.2 Research Institutes
      12.10.3 Biotechnology
      12.10.4 Others
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Medical Central Imaging Service Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Medical Central Imaging Service Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Medical Central Imaging Service Market Size Forecast by Type
      13.6.1 Standardized Reading Protocols
      13.6.2 Central Expert Image Analysis
      13.6.3 Image Quality Control
      13.6.4 Others
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Medical Central Imaging Service Market Size Forecast by Applications
      13.10.1 Pharmaceutical
      13.10.2 Research Institutes
      13.10.3 Biotechnology
      13.10.4 Others
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Medical Central Imaging Service Market: Competitive Dashboard
   14.2 Global Medical Central Imaging Service Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 ICON
      14.3.2 ERT
      14.3.3 McLaren
      14.3.4 Bioclinica
      14.3.5 Parexel
      14.3.6 BioTelemetry
      14.3.7 ProScan Imaging
      14.3.8 Imaging Endpoints
      14.3.9 Radiant Sage
      14.3.10 Micron, Inc.
      14.3.11 Intrinsic Imaging
      14.3.12 Median Technologies
      14.3.13 Cardiovascular Imaging Technologies
      14.3.14 Banook Group

Our Trusted Clients

Contact Us